WASHINGTON, DC - NOVEMBER 6: U.S. President Donald Trump, joined by members of the pharmaceutical industry and administration officials, delivers remarks on lowering drug prices in the Oval Office at the White House. Trump announced that his administration has reached agreements with drugmakers Eli Lilly and Novo Nordisk that would lower the price of some GLP-1 weight loss medications on the soon-to-launch TrumpRx platform as well as the public programs, Medicare and Medicaid. But details remain unclear. (Photo by Andrew Harnik/Getty Images) Getty Images

President Trump announced today that his administration has reached agreements with drug manufacturers Novo Nordisk and Eli Lilly on lowering the price of certain weight loss medications on the soon-to-launch TrumpRx platform as well

See Full Page